Company: ARMP
Filing Date: 2025-12-01
Form Type: 424B5
Source: 0001104659-25-117382
Chunk: 54

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-12-01
Form: 424B5
Chunk 54
---
 take place as long as it complies with certain fair price provisions of the statute or is approved
by a majority of the votes entitled to be counted within each voting group entitled to vote separately on the transaction (excluding the
acquiring person’s shares or shares over which the acquiring person has voting control) at an annual or special meeting of shareholders.

Articles of Incorporation and Bylaws

The provisions of our articles
of incorporation and bylaws may delay or discourage transactions involving an actual or potential change in our control or change in our
management, including transactions in which shareholders might otherwise receive a premium for their shares or transactions that our shareholders
might otherwise deem to be in their best interests. Therefore, these provisions could adversely affect the price of our common stock.
Among other things, our articles of incorporation and bylaws, as applicable:

| · | permit our board of directors to issue up to                                                                                            
 10,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate (including the right to approve 
 an acquisition or other change in our control);                                                                                         |

<div align='center'>16</div>

| · | provide that shareholders seeking to present                                                                                             
 proposals before a meeting of shareholders or to nominate candidates for election as directors at a meeting of shareholders must provide 
 advance notice in writing in a timely manner and also specify requirements as to the form and content of a shareholder’s notice;         |

| · | provide that directors may be removed only for                                                                                      
 cause by the holders of not less than two-thirds of the shares entitled to elect the director or directors whose removal is sought; |

| · | require the vote of the holders of at least two-thirds                                                       
 of the issued and outstanding shares to amend or repeal certain provisions of our articles of incorporation; |

| · | require the vote of the holders of at least two-thirds                                                                      
 of the issued and outstanding shares to approve a “Business Combination” (as defined in our articles of incorporation) that 
 is not approved by the “Continuing Directors”;                                                                              |

| · | require the approval of a majority of the Continuing                                                                                     
 Directors to adopt, amend or repeal the bylaws that may be amended or repealed by the board of directors and require the approval of the 
 holders of not less than two-thirds of the outstanding shares to adopt, amend or repeal our bylaws; and                                  |

| · | does not provide for cumulative voting rights. |

NYSE American Listing

Our common stock is listed
on the NYSE American under the